This gets more confusing when a recent study revealed that targeting FOXO1 by miR-5188 is necessary for the activation of PI3K/AKT/c-JUN signaling pathway in U87 and U251 glioma cell lines, supporting the tumor-suppressive side of FOXO1 [138]. The gene discussed is FOXO1; the disease is neoplasm.